1066697

Mark A. Jacobs, MD — FEI 3007924714

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)